Rilos (200 mg+750 mg+200 iu) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Cratus Life Care. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Vit D3, Glucosamine Sulphate,Methyl Sulfonyl Methane. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 49 (arround $0.686 US Dollar)
The main active ingredients or salts in Rilos (200 mg+750 mg+200 iu) are :
Vit D3-200 iu
Glucosamine Sulphate-750 mg
Methyl Sulfonyl Methane-200 mg
Vit D3 Indication (Prescribed for or used as): Vitamin D deficiency
For more details on Vit D3, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Vit D3..
Glucosamine Sulphate Indication (Prescribed for or used as):
For more details on Glucosamine Sulphate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Glucosamine Sulphate..
Methyl Sulfonyl Methane Indication (Prescribed for or used as): Dietary supplement, which has been lately used in the management of osteoarthritis in combination with glucosamine and/or chondrotin.
For more details on Methyl Sulfonyl Methane, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Methyl Sulfonyl Methane..
Rilos (200 mg+750 mg+200 iu) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Rilos (200 mg+750 mg+200 iu), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Vit D3-200 iu Glucosamine Sulphate-750 mg Methyl Sulfonyl Methane-200 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.